DJIA 17,958.43 -76.50 -0.42%
NASDAQ 5,019.34 24.74 0.50%
S&P 500 2,098.62 -1.78 -0.08%
market minute promo

MannKind Corp (NASDAQ: MNKD)

4.96 0.03 (0.51%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $4.96 0.51%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.94
Previous Close $4.93
Daily Range $4.88 - $5.00
52-Week Range $4.45 - $11.48
Market Cap $2.0B
P/E Ratio -9.67
Dividend (Yield) $0.00 (0.0%)
Volume 2,818,851
Average Daily Volume 3,559,988
Current FY EPS -$0.34




Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website:

News & Commentary Rss Feed

3 Questions to Ask Before You Buy a Biotech Stock

One Motley Fool analyst explains the key questions investors should answer before buying biotech stocks.

Pain-Free Blood Tests? Sign Me Up!

A small, Wisconsin-based company could be on the verge of developing a revolutionary new blood test that is virtually pain-free. Find out how personalized healthcare is transforming the medical field.

8 Analyst Stocks Under $10 With Massive Upside Calls

What's Afrezza's Ultimate Potential For MannKind?

Colorectal cancer biotech Xbiotech prices $76 million IPO at $19 midpoint

Short Sellers Increase Their Bets Against Biotech Stocks

Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind

MNKD May 29th Options Begin Trading

MannKind Corporation Shares Were Rocked in March -- Here's Why

MannKind stock was hammered in March. Find out what caused shares to lose 20% of their value and whether this dip represents a genuine buying opportunity.

'Mad Money' Lightning Round: Avoid MannKind and Alibaba

See More MNKD News...

MNKD's Top Competitors

MNKD $4.96 (0.51%)
Current stock: MNKD
AMGN $168.20 (1.34%)
Current stock: AMGN
GILD $105.38 (4.69%)
Current stock: GILD
BIIB $420.17 (-0.65%)
Current stock: BIIB